Abstract
The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have